10 Results for "

APJ antagonist

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "APJ antagonist" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-103254
CAS No.: 877636-42-5
Purity:  99.55%
Research Areas:  

Neurological Disease

ML221 is a potent apelin (APJ) functional antagonist, inhibiting apelin-13-mediated activation of APJ, with IC50s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and EC80 of 10 nM in both assays.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-122197
CAS No.: 2579689-83-9
Purity:  99.88%
Research Areas:  

Cancer

ML339 is a selective CXCR6 antagonist with an IC50 of 140 nM. ML339 antagonizes β-arrestin recruitment and cAMP signaling pathway of human CXCR6 receptor induced by CXCL16, with IC50 of 0.3 μM and 1.4 μM, respectively. ML339 shows weaker activity against the recruitment of β-arrestin in mouse CXCR6 receptors, with an IC50 of 18 μM. ML339 has no inhibitory effect on CXCR5CXCR4CXCR6 and apelin receptor (APJ), with IC50 >79 μM. ML339 has the potential to promote the development of prostate cancer research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P7061A
Research Areas:  

Infection Endocrinology

ALX 40-4C Trifluoroacetate is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1; ALX 40-4C Trifluoroacetate also acts as an antagonist of the APJ receptor, with an IC50 of 2.9 μM.
loading...
    loading...
Cat. No.: HY-P2271
CAS No.: 1313027-43-8
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cancer

MM 54 (compound 5) is a competitive antagonist at APJ, with an IC50 of 93 nM. MM 54 behaves as a potent and selective inhibitor of apelin binding and APLNR activation .
loading...
    loading...
Cat. No.: HY-P3162A
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

(Ala13)-Apelin-13 TFA is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 TFA inhibits gastric motility through vagal cholinergic pathway .
loading...
    loading...
Cat. No.: HY-175818
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cancer

APJ antagonist-1 is an apelin receptor (APJ) antagonist. APJ antagonist-1 shows strong β-arrestin inhibition with an IC50 of 3.1 μM. APJ antagonist-1 selectively inhibits APJ-overexpressing cancer cells and suppresses apelin-induced endothelial cell migration. APJ antagonist-1exhibits high metabolic stability. APJ antagonist-1 can used for the studies of ovarian cancer and tumor angiogenesis .
loading...
    loading...
Cat. No.: HY-P7061
CAS No.: 143413-49-4
Research Areas:  

Infection Endocrinology

ALX 40-4C is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1; ALX 40-4C Trifluoroacetate also acts as an antagonist of the APJ receptor, with an IC50 of 2.9 μM.
loading...
    loading...
Cat. No.: HY-P3162
CAS No.: 568565-11-7
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

(Ala13)-Apelin-13 is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 inhibits gastric motility through vagal cholinergic pathway .
loading...
    loading...
Cat. No.: HY-181540
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cancer

YL-GB063 is an Apelin receptor (APJ) antagonist. YL-GB063 inhibits Apelin-induced APJ β-arrestin recruitment (IC50 of 3.1 μM in HTLA cells). YL-GB063 has anti-cancer activity against ovarian cancer .
loading...
    loading...
Cat. No.: HY-103254R
CAS No.: 877636-42-5
ML221 (Standard) is the analytical standard of ML221 (HY-103254). This product is intended for research and analytical applications. ML221 is a potent apelin (APJ) functional antagonist, inhibiting apelin-13-mediated activation of APJ, with IC50s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and EC80 of 10 nM in both assays.
loading...
    loading...